- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
INSCX™ exchange announces details of a Seminar with attendees from UK regulation, enforcement, toxicology agencies, insurers, upstream and downstream users to present the Exchange mechanism for real-time trade reporting of Nanomaterials (NMs). The event will offer nanoproducers, downstream users, insurers and regulation agencies the opportunity to learn more of the Exchange trade reporting system specific to NMs. Delegates will also be invited to engage to present views as to how to proceed toward effective, industry-supported regulatory oversight of nanomaterials serving both commercial and societal interest. The Seminar is to be held at Sutton Hall (Earl Rooms), Macclesfield, Cheshire near the City of Manchester on Thursday, May 1st commencing at 11.00 am.
Since live launch in 2011, INSCX™ exchange has operated a systematic producer registration/material listing process incorporating a dedicated trade reporting mechanic to record actual trade referred to as Downstream Audit Sequencing (DAS). The combined mechanic establishes the exact specification of nanomaterial supplied onto the market on a trade-by-trade basis, independent proof of conformity to specification and a means to sequence use of the NM exchange through the conversion process to end product, object or device.
INSCX™ proposes access to trade information collected via the DAS mechanic be offered exclusively and securely to official regulation agencies, FCA approved insurers and the Institute of Occupational Medicine. The objective of DAS is to enable transparency in trade of NMs for the purposes of aiding a regulatory structure than can command broad industry support, advance insurability and the goal of industry-relevant toxicology assessment of NMs, while safeguarding the rights of producers and downstream users to commercial confidentiality.
In reference to the seminar, Professor Jeremy Ramsden, Chief Technical Officer, INSCX™ commented;
"The DAS mechanic provided by INSCX enables real-time transparency, track/trace and a basis for furthering specific toxicology analysis of nanomaterials used in industry, while safeguarding the commercial confidences of producers and downstream users of these materials. Trade reporting and the safeguarding of buyer/seller confidences constitute a basic function of an Exchange system, and INSCX provides this to the emerging NM industry. Regulation agencies and insurers we suggest can use DAS access to advance their respective oversight objectives confident the effort is directed to real-world commercial activity."
Continuing, an Exchange spokesperson added;
"While the seminar is geared to provide wider insight to DAS itself, an equally important purpose is to encourage greater interaction between regulation/enforcement agencies, insurers and NM upstream/downstream users. Our view remains that commercial interest in NMs can quickly adopt the DAS mechanic on a national, regional or indeed, global basis without cost burden, advance commercial prudence in terms of accountability and indemnification, while aiding transparency for official regulation agencies and the insurance community.
INSCX™ exchange encourages the ethos of collaboration between NM stakeholders to devise effective regulation based on proven commercial use of NMs. The DAS mechanic is thus offered as a practical initiative sharing the view that transparency can create and retain trust to compliment the commercial and societal potential of nanoscience.
Seminar attendance is open to Exchange commercial members and non-members alike, and is to be held at Sutton Hall (Earls Rooms), Macclesfield, Cheshire near the City of Manchester on Thursday, May 1st commencing at 11.00 am.
Delegates/Attendees to include DEFRA, Health & Safety Executive (HSE), Environment Agency, Institute of Occupational Medicine, SAFENANO, Lloyds of London, AssuredNano®, and insurance broker of record to the Exchange, Locktons.
Primary objective is to present (DAS), the Downstream Audit Sequencing mechanism employed by the Exchange which constitutes a working, ready-to-market real-time system for reporting of commercial trade in engineered nanomaterials to aid regulatory oversight, lifecycle analysis and transparency to encourage insurability.
Invitation extended to include nanomaterials producers and downstream users, the latter across a broad spectrum of industrial areas from polymers, composites, metals, lubcriants and electronics.
Enabling interaction between producers/users, regulators and insurers with the aim of aiding commercial and societal oversight of nanomaterials.
Seminar attendance by Exchange invitation only. To reserve a booking and receive the Seminar Flyer, contact Tel: 0044 1782 454 144 or e-mail:
INSCX™ exchange [Central Clearing Limited] is a commercial user commodity exchange for physical delivery of underlying materials against listed contracts. Registration Number: 07787171. www.inscx.com Disclaimer: To the extent the user is entitled to disclose and distribute this document, the user may forward, distribute, and/or photocopy this copyrighted document only if unaltered and complete, including all of its headers, footers, disclaimers, and other information to appropriate parties only. INSCX™ exchange, Merchant Member firms thereof and/or Members admitted to the Official List [the “parties”] do not guarantee, represent, warrant, or otherwise guarantee, expressly or impliedly, the merchantability of material(s) supplied against contract(s), fitness for a particular purpose, or suitability of underlying material(s). The user is solely responsible for all determinations regarding any use of underlying material(s) supplied against contract(s) and any process in its territories of interest. The parties expressly disclaim liability for any loss, damage, or injury directly or indirectly suffered or incurred as a result of, or related to anyone using the underlying material(s). Exchange provision is enabled for user guidance on purchase of supporting Technical Support Contract(s) [TSC] relevant to the material(s) and reference to regulated and industry approved insurers. Listed contract(s) are not promoted as suitable for investment purposes, as defined by the UK Financial Services and Markets Act 2000 (Regulated Activities) provisions. Underlying material(s) delivered against contract(s) are subject to independent assurance to specification(s), good delivery, and in the case of engineered nanomaterials [NMs], compliance with Nanomaterials Safety, Health & Environment [SHE] good practices and INSCX™ “Track and Trace”.
For more information, please click here
T: 44 1782 454 144
Copyright © INSCX™If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Soft decoupling of organic molecules on metal June 23rd, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016